Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Gilmer

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Chemico-Biological Interactions|January 24, 2006
Synthesis and structure activity relationships (SAR) of a new class of potent and selective butyrylcholinesterase inhibitorsJoanne M Gaynor, Gerald P Dillon, Sean Reidy, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2014
Part Two: Evaluation of N-methylbupropion as a Potential Bupropion ProdrugPaul Matthew O'Byrne, Robert Williams, John J Walsh, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2013
A methodology for detection and quantification of esterase activityAna L Simplício, Ana S Coroadinha, John F Gilmer, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 16, 2010
The aqueous stability of bupropionPaul M O'Byrne, Robert Williams, John J Walsh, et al.
Pharmaceuticals (Basel, Switzerland)|May 17, 2014
Synthesis, screening and pharmacokinetic evaluation of potential prodrugs of bupropion. Part one: in vitro developmentPaul Matthew O'Byrne, Robert Williams, John J Walsh, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 5, 2002
Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinateJohn F Gilmer, Louise M Moriarty, Maeve N Lally, et al.
Biomolecules|May 30, 2020
Novel Barbiturate-Nitrate Compounds Inhibit the Upregulation of Matrix Metalloproteinase-9 Gene Expression in Intestinal Inflammation through a cGMP-Mediated PathwayShane O'Sullivan, Jun Wang, Marek W Radomski, et al.
Biochimica Et Biophysica Acta|December 17, 2013
Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactionsShane O'Sullivan, Carlos Medina, Mark Ledwidge, et al.
Oncotarget|November 27, 2016
Unconjugated secondary bile acids activate the unfolded protein response and induce golgi fragmentation via a src-kinase-dependant mechanismRuchika Sharma, Francis Quilty, John F Gilmer, et al.
Molecules (Basel, Switzerland)|August 19, 2016
Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's DiseaseMike Jones, Jun Wang, Shona Harmon, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Chemico-Biological Interactions|January 24, 2006
Synthesis and structure activity relationships (SAR) of a new class of potent and selective butyrylcholinesterase inhibitorsJoanne M Gaynor, Gerald P Dillon, Sean Reidy, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2014
Part Two: Evaluation of N-methylbupropion as a Potential Bupropion ProdrugPaul Matthew O'Byrne, Robert Williams, John J Walsh, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2013
A methodology for detection and quantification of esterase activityAna L Simplício, Ana S Coroadinha, John F Gilmer, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 16, 2010
The aqueous stability of bupropionPaul M O'Byrne, Robert Williams, John J Walsh, et al.
Pharmaceuticals (Basel, Switzerland)|May 17, 2014
Synthesis, screening and pharmacokinetic evaluation of potential prodrugs of bupropion. Part one: in vitro developmentPaul Matthew O'Byrne, Robert Williams, John J Walsh, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 5, 2002
Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinateJohn F Gilmer, Louise M Moriarty, Maeve N Lally, et al.
Biomolecules|May 30, 2020
Novel Barbiturate-Nitrate Compounds Inhibit the Upregulation of Matrix Metalloproteinase-9 Gene Expression in Intestinal Inflammation through a cGMP-Mediated PathwayShane O'Sullivan, Jun Wang, Marek W Radomski, et al.
Biochimica Et Biophysica Acta|December 17, 2013
Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactionsShane O'Sullivan, Carlos Medina, Mark Ledwidge, et al.
Oncotarget|November 27, 2016
Unconjugated secondary bile acids activate the unfolded protein response and induce golgi fragmentation via a src-kinase-dependant mechanismRuchika Sharma, Francis Quilty, John F Gilmer, et al.
Molecules (Basel, Switzerland)|August 19, 2016
Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's DiseaseMike Jones, Jun Wang, Shona Harmon, et al.
Pageof 6